top of page
Logo SurgMark
A woman in a medical laboratory
Logo SurgMark

We are a company specializing in innovative solutions in medical technology and biotechnology. Our team is interdisciplinary: the shareholders come from the fields of medicine, development and the start-up scene.

​

We combine expertise

with a keen eye for market potential.

yellow button from the SchurSign logo

Our mission

SurgMark is committed to developing innovative solutions for the diagnosis and treatment of breast cancer and other tumors. Through our latest tool, SchurSign®, we integrate expertise from both breast surgery and biomaterial research.

A young man in the lab at the microscope working with SchurSign
yellow button from the SchurSign logo

We are more than the sum of its many years of experience

Dr. Christine König, PhD
Dr. Thomas Freier, PhD
Dr. Rivelino Montenegro, PhD

Dr. Christine König, PhD

CEO, experienced founder and CEO in the life sciences industry, over 20 years experience as serial entrepreneur and international top management consultant.

Dr. Thomas Freier, PhD

Sen. VP, product development and quality assurance, chemist and serial entrepreneur in the biomaterials- and medical sciences.

Dr. Rivelino Montenegro, PhD

Sen. VP, regulatory affairs and chemistry, multiple times entrepreneur in the medical field and experienced chemist in materials science.

Dr. Frank Schure, MD
Dr. Peter A. Meier, MD, MBA
Dr. Megan Kalambo  Scientific Advisor

Dr. Frank Schure, MD

CCO, gynecologist and obstetrician, Senior Surgeon in breast and oncology, specialist for ultrasound guided surgery and edge of specimen ultrasound.

Dr. Peter A. Meier, MD, MBA

CMO, entrepreneur and advisor with over 20 yrs. senior management and business development experience in the medical device industry.

Dr. Megan Kalambo, MD

Dr. Megan Kalambo is an Associate Professor in the Department of Breast Imaging at The University of Texas MD Anderson Cancer Center (MDACC)

bottom of page